Lisinopril And Hydrochlorothiazide recalls
Lisinopril And Hydrochlorothiazide products have been recalled 5 times, most recently on 23 Jul 2025. The recalling company is usually Lupin Pharmaceuticals. The most common reason is manufacturing (cgmp) deviations.
Total recalls5since 2016
Last 12 months0reported
Class I00% of total
Ongoing1latest 23 Jul 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 4 80%Class III 1 20%
Why lisinopril and hydrochlorothiazide is recalled
Companies
Product types
By year
Ongoing lisinopril and hydrochlorothiazide recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg recalledLisinopril And Hydrochlorothiazide | Lupin Pharmaceuticals | Packaging Defects | Nationwide |
All lisinopril and hydrochlorothiazide recalls, newest first
5 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg recalledLisinopril And Hydrochlorothiazide | Lupin Pharmaceuticals | Packaging Defects | Nationwide |
| Drug | CLASS II | Lisinopril and Hydrochlorothiazide Tablets USP, 10mg/12.5mg recalledLisinopril And Hydrochlorothiazide | Cardinal Healthcare | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Lisinopril and Hydrochlorothiazide Tablets USP, 10 mg/12.5 mg recalledLisinopril And Hydrochlorothiazide | Lupin Pharmaceuticals | Other | Nationwide |
| Drug | CLASS II | Lisinopril and Hydrochlorothiazide Tablets USP, 20 mg/12.5 mg recalledLisinopril And Hydrochlorothiazide | Lupin Pharmaceuticals | Other | Nationwide |
| Drug | CLASS III | Lisinopril & Hydrochlorothiazide Tables, USP 20mg/12.5mg recalledLisinopril And Hydrochlorothiazide | Lupin Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.